Clinical Trial Update: A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for EO2401 in metastatic adrenocortical carcinoma and malignant pheochromocytoma/paraganglioma reports termination of the study, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma
• Paraganglioma
• Pheochromocytoma

Drugs mentioned

• EO2401

Snippet

Sponsor: Enterome | Conditions: Adrenocortical Carcinoma, Pheochromocytoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-01-30